Search

Two friends, two countries; one disease, one network to fight it. We spoke to two leaders of DNDi’s Leishmaniasis East Africa Network.

How a scattershot lunar alliance launched a cybernetic rocket at SARS-CoV-2

In recent years, Advanced Therapy Medicinal Products (ATMPs) have evolved into a promising and highly hoped-for medical approach to cure a broad spectrum of diseases.

Where did DNDi come from – and where is it going? We ask the nonprofit organization’s chief for a rundown

We sit down with Akhil Ravi, CEO of Aurigene Pharmaceutical Services, to learn about his career and passion for the industry.

Catalent’s proven GPEx® platform creates stable, high-yielding mammalian cell lines, with high speed and efficiency

Clinical trials? Cancer R&D? AstraZeneca’s Matthew Ellis shares his views on the future of pharma.

Packaging should be about patients, but how can we turn a decades-old philosophy into the status quo?

How we can begin overcoming patients’ fears and misconceptions of cell and gene therapy

How pharma is working to develop efficient and patient-centric trials.